Corporate News 08-Jun-23
Biocon's API unit in Bangalore receives GMP compliance certificate
Biocon announced that its Active Pharmaceutical Ingredient (API) manufacturing facility located in Bangalore has received a certificate of GMP compliance from the Competent Authority of Germany, following an EU GMP inspection that was conducted in February 2023.
Previous News
Biocon consolidated net profit declines 56.74% in the March 2024 quarter
( Results - Announcements 16-May-24 18:25 )
Biocon announces board meeting date
( Corporate News - 04-Oct-24 09:29 )
Biocon Ltd up for five straight sessions
( Hot Pursuit - 19-Feb-24 13:00 )
Volumes jump at Biocon Ltd counter
( Hot Pursuit - 28-Feb-23 11:00 )
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
( Hot Pursuit - 15-Jun-24 16:32 )
Biocon to conduct board meeting
( Corporate News - 18-Jul-24 10:37 )
Biocon PAT slides 57% to Rs 136 crore in Q4 FY24
( Hot Pursuit - 17-May-24 10:37 )
Biocon Ltd up for fifth session
( Hot Pursuit - 22-Aug-24 13:00 )
Biocon to declare Quarterly Result
( Corporate News - 11-Jan-24 11:42 )
Biocon Biologics update on USFDA's CRL issued to partner Viatris (Mylan)
( Corporate News - 13-Feb-23 09:20 )
Biocon Biologics' new mAbs drug substance facility undergoes HPRA's GMP inspection
( Corporate News - 04-May-22 08:33 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
